Steadymed News (NASDAQ:STDY)

Add to My Stocks
$4.73 $0 (0%) STDY stock closing price Aug 30, 2018 (Closing)
WeissLaw LLP Investigates SteadyMed Ltd.   by PRNews on May 02, 2018
United Therapeutics to Acquire SteadyMed Ltd.   by Globe Newswire on Apr 30, 2018
SteadyMed Submits New Drug Application for Trevyent®   by Globe Newswire on Jun 30, 2017
SteadyMed Raises $30 Million in Private Placement   by Globe Newswire on Apr 21, 2017

STDY Industry Peers

Company Price Change (%)
Contrafect (CFRX)1.630.01 (0.61%)
Juniper Pharma (JNP)11.50 (0%)
Kun Run Biotech (KURU)4.980 (0%)
Teva Pharmaceutical (TEVA)24.830.19 (0.77%)
Athersys (ATHX)1.860.01 (0.53%)
Neuroderm (NDRM)38.850 (0%)
Pacira Pharma (PCRX)520.65 (1.27%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
PYXUS INTL INC (PYX)26.15.7 (27.94%)
Acadia Pharma (ACAD)19.114.01 (26.56%)
Conatus Pharma (CNAT)5.540.82 (17.37%)
Mechel PAO (MTL)3.420.5 (17.12%)
American Superconductor (AMSC)7.331.02 (16.16%)
Galectin Therapeutics (GALT)6.930.88 (14.55%)
Kandi Technologies (KNDI)5.650.7 (14.14%)
Top gainers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Sep 21, 2018
CompanyPriceChange (%)
OncoMed Pharma (OMED)2.40.4 (14.29%)
Thor Industries (THO)91.9513.69 (12.96%)
Seaspan (SSW)8.210.95 (10.37%)
Willian Lyon Homes (WLH)17.21.45 (7.77%)
Golden Entertainment (GDEN)24.732.08 (7.76%)
Rigel Pharma (RIGL)3.320.27 (7.52%)
MOLECULAR TEMPL (MTEM)5.790.46 (7.36%)
Top losers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Sep 21, 2018